VCA Specialty Update Symposium
SUNDAY 24 SEPTEMBER 2017 | 09.00 – 12.50
VCA Specialty Update Symposium
09.00 – 11.00 VCA Session
CHAIRS: Gerald Brandacher, Baltimore, United States
Emmanuel Morelon, Lyon, France
09:00 Uterus transplantation: current status and future
Mats Brannstrom, Gothenburg, Sweden
09:30 Penis transplantation: a viable option to restore form and function
Frank Graewe, Stellenbosch, South Africa
10:00 Regenerative medicine and VCA - competitors or perfect couple?
Alexandra Iordachescu, Birmingham, United Kingdom
10:30 Novel technologies for local skin-specific drug delivery
Constantin Coussios, Oxford, United Kingdom
11.10 – 12.50 Joint BSC and VCA Session
CHAIRS: Gerald Brandacher, Baltimore, United States
Nina Pilat-Michalek, Vienna, Austria
11:10 VCA and regenerative medicine: a perfect couple?
Gerald Brandacher, Baltimore, United States
11:20 Creating stem cell niches in vitro
Martin J. Hoogduijn, Rotterdam, The Netherlands
11:50 Engineering functional tissues: The Holy Grail or an attainable goal?
Tahera Ansari, Harrow, United Kingdom
12:20 Pediatric reconstructive transplantation
Lawrence Levin, Philadelphia, United States
______________________________________________________________________________________________________
VCA in pills:
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This committee brings together 10 representatives of major European teams at the forefront in this field.
Goals:
Our goal is to raise the scientific and clinical development of Vascularized Composite Allotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians for information and exchange.
______________________________________________________________________________________________________
Objectives:
- Understand the risks and limits of face and upper limb transplantation
- Discuss and implement new data to characterize chronic rejection
- Discuss the contribution of animal models in VCA
- Discuss alternatives strategies for patients’ management
Target audience:
Surgeons, physicians, researchers, transplant coordinators